
Cardiac Masses on Echocardiography: Atrial Myxoma and Metastatic Melanoma
Two cases, a left atrial myxoma and metastatic melanoma to the heart, showing how echocardiography helps detect and characterise cardiac masses.
Articles on heart disease, prevention, and cardiac imaging by Dr Reza Moazzeni, MD FRACP, cardiologist in Sydney.

Two cases, a left atrial myxoma and metastatic melanoma to the heart, showing how echocardiography helps detect and characterise cardiac masses.

How echocardiography is used before, during and after cancer treatment to assess heart function and detect cardiotoxicity, including the role of strain imaging.

How echocardiography helps look for a heart source of stroke, when TTE, TOE or a bubble study is used, and how findings can change treatment.

A clinician summary of the 2026 ACC/AHA dyslipidaemia guideline: PREVENT risk assessment, LDL-C goals, Lp(a), ApoB, CAC and therapy, with Australian notes.

What triglycerides are, what your result means, and the diet, alcohol, weight and activity changes that can lower them, plus when medication is considered.

What a stress echocardiogram is, why it is requested, how to prepare, what happens during the test and what the results mean.

What an echocardiogram can and cannot show, the main types of echo, what happens during the scan and how to understand your results.

A review of lipoprotein(a): why it matters, who should be tested, how to interpret results, current management and emerging Lp(a)-lowering therapies.
How alcohol affects blood pressure, atrial fibrillation, stroke risk and the heart muscle, what a standard drink is in Australia and how to cut back.

Lipoedema is a painful, symmetrical fat disorder mostly affecting women. Learn how it differs from obesity and lymphoedema, how it is diagnosed and managed.
A case of a 38-year-old man with an LDL-C of 10.1 mmol/L, working through how to tell familial hypercholesterolaemia from other severe hyperlipidaemia.
How inclisiran lowers LDL cholesterol by silencing PCSK9 production in the liver, with trial evidence, safety, twice-yearly dosing and PBS access in Australia.